Tuan Zea Tan
Tuan Zea Tan
Cancer Science Institute of Singapore
Verified email at nus.edu.sg
Title
Cited by
Cited by
Year
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
TZ Tan, QH Miow, Y Miki, T Noda, S Mori, RYJ Huang, JP Thiery
EMBO molecular medicine 6 (10), 1279-1293, 2014
3202014
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor …
RYJ Huang, MK Wong, TZ Tan, KT Kuay, AHC Ng, VY Chung, YS Chu, ...
Cell death & disease 4 (11), e915-e915, 2013
2332013
Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell–mediated lysis
I Akalay, B Janji, M Hasmim, MZ Noman, F André, P De Cremoux, ...
Cancer research 73 (8), 2418-2427, 2013
2102013
Dual role of autophagy in hallmarks of cancer
SS Singh, S Vats, AYQ Chia, TZ Tan, S Deng, MS Ong, F Arfuso, CT Yap, ...
Oncogene 37 (9), 1142-1158, 2018
1422018
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ...
EMBO molecular medicine 5 (7), 1051-1066, 2013
1402013
Lgr5 marks stem/progenitor cells in ovary and tubal epithelia
A Ng, S Tan, G Singh, P Rizk, Y Swathi, TZ Tan, RYJ Huang, ...
Nature cell biology 16 (8), 745-757, 2014
1372014
A novel cognitive interpretation of breast cancer thermography with complementary learning fuzzy neural memory structure
TZ Tan, C Quek, GS Ng, EYK Ng
Expert Systems with Applications 33 (3), 652-666, 2007
1242007
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
BL Khoo, SC Lee, P Kumar, TZ Tan, ME Warkiani, SGW Ow, S Nandi, ...
Oncotarget 6 (17), 15578, 2015
1012015
DEAD-box helicase DP103 defines metastatic potential of human breast cancers
EM Shin, HS Hay, MH Lee, JN Goh, TZ Tan, YP Sen, SW Lim, EM Yousef, ...
The Journal of clinical investigation 124 (9), 3807-3824, 2014
912014
FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway
M Asad, MK Wong, TZ Tan, M Choolani, J Low, S Mori, D Virshup, ...
Cell death & disease 5 (7), e1346-e1346, 2014
872014
Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
QH Miow, TZ Tan, J Ye, JA Lau, T Yokomizo, JP Thiery, S Mori
Oncogene 34 (15), 1899-1907, 2015
852015
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
MZ Noman, B Janji, A Abdou, M Hasmim, S Terry, TZ Tan, ...
Oncoimmunology 6 (1), e1263412, 2017
752017
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification
VY Chung, TZ Tan, M Tan, MK Wong, KT Kuay, Z Yang, J Ye, J Muller, ...
Scientific reports 6 (1), 1-15, 2016
732016
Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects
CQ Wang, V Krishnan, LS Tay, DWL Chin, CP Koh, JY Chooi, GSS Nah, ...
Cell reports 8 (3), 767-782, 2014
692014
Molecular characterization of breast cancer CTCs associated with brain metastasis
D Boral, M Vishnoi, HN Liu, W Yin, ML Sprouse, A Scamardo, DS Hong, ...
Nature communications 8 (1), 1-10, 2017
642017
Ovarian cancer diagnosis with complementary learning fuzzy neural network
TZ Tan, C Quek, GS Ng, K Razvi
Artificial intelligence in medicine 43 (3), 207-222, 2008
622008
Brain-inspired genetic complementary learning for stock market prediction
TZ Tan, C Quek, GS Ng
2005 IEEE Congress on Evolutionary Computation 3, 2653-2660, 2005
602005
SPHK1 regulates proliferation and survival responses in triple-negative breast cancer
A Datta, SY Loo, B Huang, L Wong, SSL Tan, TZ Tan, SC Lee, JP Thiery, ...
Oncotarget 5 (15), 5920, 2014
582014
Molecular subtypes of urothelial bladder cancer: results from a meta-cohort analysis of 2411 tumors
TZ Tan, M Rouanne, KT Tan, RYJ Huang, JP Thiery
European urology 75 (3), 423-432, 2019
562019
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype–specific therapeutic target for ovarian cancer
J Antony, TZ Tan, Z Kelly, J Low, M Choolani, C Recchi, H Gabra, ...
Sci. Signal. 9 (448), ra97-ra97, 2016
552016
The system can't perform the operation now. Try again later.
Articles 1–20